Press "Enter" to skip to content

New patent expiration for Fresenius Medcl drug PHOSLO

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Fresenius Medcl drug PHOSLO

Annual Drug Patent Expirations for PHOSLO
Annual Drug Patent Expirations for PHOSLO

Phoslo is a drug marketed by Fresenius Medcl and is included in two NDAs. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for PHOSLO.

The generic ingredient in PHOSLO is calcium acetate. Three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Fresenius Medcl drug PHOSLO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions